Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury:
Shixian Chen1, Hongqiu Pan2, Yongzhong Chen2
1Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
Abstract:
Reactive metabolites of anti-tuberculosis (anti-TB) drugs can result in excessive reactive oxygen species (ROS), which are responsible for drug-induced liver injury. The nuclear factor erythroid 2-related factor 2 (Nrf2) - antioxidant response elements (ARE) (Nrf2-ARE) signaling pathway plays a crucial role in protecting liver cells from ROS, inducing enzymes such as phase II metabolizing enzymes and antioxidant enzymes. Based on a Chinese anti-TB treatment cohort, a nested case-control study was performed to explore the association between 13 tag single-nucleotide polymorphisms (tagSNPs) in the NRF2, KEAP1, MAFF, MAFK genes in Nrf2-ARE signaling pathway and the risk of anti-TB drug-induced liver injury (ATLI) in 314 cases and 628 controls. Conditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) after adjusting weight and usage of hepatoprotectant. Patients carrying the TC genotype at rs4243387 or haplotype C-C (rs2001350-rs6726395) in NRF2 were at an increased risk of ATLI (adjusted OR = 1.362, 95% CI: 1.017-1.824, P = 0.038; adjusted OR = 2.503, 95% CI: 1.273-4.921, P = 0.008, respectively), whereas patients carrying TC genotype at rs2267373 or haplotype C-G-C (rs2267373-rs4444637-rs4821767) in MAFF were at a reduced risk of ATLI (adjusted OR = 0.712, 95% CI: 0.532-0.953, P = 0.022; adjusted OR = 0.753, 95% CI: 0.587-0.965, P = 0.025, respectively). Subgroup analysis also detected a significant association between multiple tagSNPs (rs4821767 and rs4444637 in MAFF, rs4720833 in MAFK) and specific clinical patterns of liver injury under different genetic models. This study shows that genetic polymorphisms of NRF2, MAFF and MAFK may contribute to the susceptibility to ATLI in the Chinese anti-TB treatment population.
Insights
Genetic variations in NRF2, MAFF, and MAFK influence anti-tuberculosis drug-induced liver injury (ATLI) risk. Specific genotypes increase susceptibility, while others offer protection in the Chinese population.
Area of Science:
- Pharmacogenomics
- Hepatology
- Tuberculosis Research
Background:
- Reactive metabolites of anti-tuberculosis (anti-TB) drugs generate reactive oxygen species (ROS), leading to drug-induced liver injury (DILI).
- The Nrf2-ARE signaling pathway is vital for cellular defense against ROS by inducing antioxidant and phase II metabolizing enzymes.
Purpose of the Study:
- To investigate the association between genetic polymorphisms in the Nrf2-ARE pathway genes (NRF2, KEAP1, MAFF, MAFK) and the risk of anti-TB drug-induced liver injury (ATLI).
- To identify specific tag single-nucleotide polymorphisms (tagSNPs) and haplotypes that predict ATLI susceptibility in a Chinese anti-TB treatment cohort.
Main Methods:
- A nested case-control study involving 314 ATLI cases and 628 controls from a Chinese anti-TB treatment cohort.
- Analysis of 13 tagSNPs in NRF2, KEAP1, MAFF, and MAFK genes using conditional logistic regression, adjusting for weight and hepatoprotectant use.
Main Results:
- Carriage of the TC genotype at rs4243387 in NRF2 or the C-C haplotype (rs2001350-rs6726395) was associated with an increased risk of ATLI.
- Carriage of the TC genotype at rs2267373 in MAFF or the C-G-C haplotype (rs2267373-rs4444637-rs4821767) was associated with a reduced risk of ATLI.
- Subgroup analyses revealed significant associations between specific tagSNPs in MAFF and MAFK and distinct clinical patterns of liver injury.
Conclusions:
- Genetic polymorphisms in NRF2, MAFF, and MAFK genes are significant contributors to ATLI susceptibility in the Chinese population undergoing anti-TB treatment.
- These findings highlight the potential of pharmacogenomic approaches for predicting and potentially preventing ATLI in TB patients.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...


